Chapters

Transcript

Video

ASCO 2023: Breast Cancer Research Presented by Sara Tolaney, MD

Data shows antibody-drug conjugate offers significant survival benefit for patients with HR-positive/HER2-negative metastatic breast cancer. 


Published

June 21, 2023

Created by

Dana-Farber

Related Presenters

Sara Tolaney, MD, MPH

Sara Tolaney, MD, MPH

Medical Oncology

Chief, Division of Breast Oncology, Susan F. Smith Center for Women's Cancers

View full profile